Drug maker Orchid Chemicals & Pharmaceuticals today said it has received approval from the US drug regulator for its anti-hypertensive tablets.
The company has received approval from the US Food and Drug Administration (FDA) for its anti-hypertensive tablets Amlodipine Besylate, the Chennai-based pharmaceuticals firm said in a filing to the Bombay Stock Exchange.
The approval has come for 2.5 mg, 5 mg and 10 mg tablets, the company said.
With this nod, "Orchid's cumulative Abbreviated New Drug Application (ANDA) approval count stands at 32 and the total ANDA filing count stands at 50," the company added.
Shares of Orchid Chemicals were trading at Rs 96.50, up 0.89 per cent in the late afternoon trade on the BSE.
